logo
Select company
Select metric
-15.84%Return on Equity
VS
Market
30
Sector
70
Industry
61
History
13
$ 27.99Close
$ 26.71 - $ 40.13 52-Week Range
Ticker Information

Ticker

SRDX

Company Name

SURMODICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

SURMODICS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SRDX - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 111.31M$ -17.63M-15.84%
3/31/2025$ 110.25M$ -19.86M-18.02%
12/31/2024$ 111.77M$ -14.41M-12.89%
9/30/2024$ 118.9M$ -11.54M-9.71%
6/30/2024$ 118.14M$ -1.4M-1.18%
3/31/2024$ 123.95M$ 13.5M10.89%
12/31/2023$ 122.15M$ 5.52M4.52%
9/30/2023$ 119.91M$ -1.54M-1.28%
6/30/2023$ 112.41M$ -22.96M-20.42%
3/31/2023$ 102.55M$ -35.95M-35.06%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SURMODICS INC's latest trailing twelve months (TTM) ROE stands at 0.86%.
  • Over the past 5 years, SURMODICS INC's average ROE has been -8.02%.
  • The median ROE for SURMODICS INC during this period was -4.57%
  • SURMODICS INC reached its highest ROE over the past 5 years at 10.89%.
  • The lowest ROE recorded by SURMODICS INC in the same timeframe -35.06%

SURMODICS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
CBLL : CERIBELL INC -28.7%OM : OUTSET MEDICAL INC -63.25%QTRX : QUANTERIX CORP -24.11%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -856.02%BFLY : BUTTERFLY NETWORK INC -26.99%RXST : RXSIGHT INC -11.6%CTKB : CYTEK BIOSCIENCES INC -1.7%NPCE : NEUROPACE INC -133.46%SMLR : SEMLER SCIENTIFIC INC 9.66%DCTH : DELCATH SYSTEMS INC 2.13%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for SURMODICS INC is calculated as follows: Net Inc. Cmn. [ $ 1.12M ] / Equity [ $ 131.06M ]
(=) ROE [ 0.86% ]

SRDX - Return on Equity, Last 5 years

-35.06%

Minimum

Mar 31, 2023

10.89%

Maximum

Mar 31, 2024

-8.02%

Average

-4.57%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%